ArticleFrontiers in aging neuroscience2016

In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Michael Gejl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.